The International Workshop on HIV Persistence During Therapy
The International Workshop on HIV Persistence During Therapy
批准号:
8288045
负责人:
Mario Stevenson
金额:
$0.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-07-01 至 2016-06-30
关键词:
AccreditationAnimal ModelAttentionCategoriesCellular biologyClinicalCommunicable DiseasesCountryDataEducational workshopFacultyFunctional disorderHIVHIV InfectionsHealth PersonnelImmunologyInfectionInflammationInternationalKnowledgeLearningMedicalMethodsNeurocognitiveNursesOralParticipantPatientsPharmacologyPhysiciansPostdoctoral FellowPremature aging syndromePublic HealthResearchResearch PersonnelScholarshipScientistSumTimeTrainingWest Indiesabstractingcontinuing medical educationdesignexperiencegraduate studentnovel therapeutic interventionnovel therapeuticspostersprogramssuccesssymposiumvirology
中文摘要
描述(由申请者提供):第五届艾滋病毒治疗期间持久性国际研讨会将于2011年12月6-9日在西印度群岛的圣马丁举行。自2003年第一期讲习班以来,“艾滋病毒持久性与宿主”的问题变得更加相关,不仅对生物学家,而且对面临长期控制持久逆转录病毒感染问题的临床医生也是如此。随着有效治疗的患者经历神经认知功能障碍、过早衰老和持续炎症,这些储存库和能够在这一水平上针对艾滋病毒的新的治疗策略受到了更多的关注。该讲习班被认为是“关于艾滋病毒宿主的参考讲习班”。该方案的形式将继续沿袭过去的成功,包括介绍新的、未公布的数据和一个专家小组,以总结该领域当前的数据。具体目标:1.将艾滋病毒持久性和潜伏期领域的医生、临床医生、科学家和临床研究人员聚集在一起,介绍和讨论科学研究和新数据。2.通过学员奖学金,为各国代表性不足的科学家、年轻研究生、护士和/或博士后研究员提供培训。3.为医生提供继续医学教育(CME)学分。教育目标:2011年计划的教育目标是在以下类别中取得进展:1.动物模型和储存库;2.细胞生物学和储存库;3.病毒学、免疫学和储存库;4.药理学、强化和储存库;5.隔室和储存库的临床影响;6.原发艾滋病毒感染和根除问题;7.新的治疗方法。设计与方法:艾滋病毒持续治疗国际研讨会将由一个国际公认的项目委员会设计,每年在西印度群岛的圣马丁举行两天半。它将包括口头和海报形式的科学演示文稿。参与者的人数将被限制在150人以内,参与者必须提交摘要以供选择作为口头或海报演示。和往年一样,抽象的选择将是极其严格的。继续医学教育认证委员会(ACCME)认可的项目将为代表和教职员工之间的正式和非正式互动提供充足的时间。
英文摘要
DESCRIPTION (provided by applicant): The Fifth International Workshop on HIV Persistence during Therapy will take place on December 6-9, 2011 in St. Martin, West Indies. Since the first edition of this workshop in 2003, the issue of "HIV Persistence & Reservoirs" has become more relevant, not only for the biologist but also for the clinician facing the problem of a long-term control of a persistent retroviral infection. As effectively treated patients experience neurocognitive dysfunction, premature aging, and persistent inflammation, more attention is paid to these reservoirs and to new therapeutic strategies capable of targeting HIV at this level. The Workshop is recognized as "THE reference workshop on HIV reservoirs." The program format will continue to follow the past successes and include presentation of new, unpublished data and a panel of experts to sum up the current data in the field. Specific Aims: 1. Bring together physicians, clinicians, scientists and clinical researchers in the HIV persistence and latency arena to present and discuss scientific research and new data. 2. Provide training of underrepresented scientists from various countries, young graduate students, nurses, and/or post-doctoral fellows through attendee scholarships. 3. Provide Continuing Medical Education (CME) credit for physicians. Educational Objectives: The educational objectives of the 2011 program are to achieve advancement in the following categories: 1. Animal Models and Reservoirs; 2. Cellular Biology and Reservoirs; 3. Virology, Immunology and Reservoirs; 4. Pharmacology, Intensification and Reservoirs; 5. Clinical Implications of Compartments and Reservoirs; 6. Primary HIV Infection and Eradication Issues; 7. New Therapeutic Approaches. Design & Methods: The International Workshop on HIV Persistence during Therapy program will be designed by an internationally-recognized Program Committee, and will take place over 2.5 days biannually in St. Martin, West Indies. It will include scientific presentations in both oral and poster presentation formats. The number of participants will be limited to 150, and participants must have submitted abstracts for selection as either an oral or poster presentation. As in previous years, abstract selection will be extremely rigorous. The Accreditation Council for Continuing Medical Education (ACCME)-accredited program will provide ample time for formal and informal interactions between delegates and faculty.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Irreversible Proviral Silencing in Myeloid Cells
-
批准号:10705469
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2023
-
负责人:Mario Stevenson
-
依托单位:
Simple Method for Screening of HIV Drug Resistance in Resource-Limited Settings
-
批准号:10384759
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2022
-
负责人:Mario Stevenson
-
依托单位:
Defining a Role for Liver Myeloid Cells in Viral Persistence under ART-SUPPLEMENT 1
-
批准号:10852118
-
项目类别:
-
资助金额:$6.02万
-
财政年份:2022
-
负责人:Mario Stevenson
-
依托单位:
Defining a Role for Liver Myeloid Cells in Viral Persistence under ART
-
批准号:10527635
-
项目类别:
-
资助金额:$46.95万
-
财政年份:2022
-
负责人:Mario Stevenson
-
依托单位:
Defining a Role for Liver Myeloid Cells in Viral Persistence under ART
-
批准号:10654037
-
项目类别:
-
资助金额:$51.04万
-
财政年份:2022
-
负责人:Mario Stevenson
-
依托单位:
Revealing HIV-1 persistence in myeloid cell reservoirs
-
批准号:10709063
-
项目类别:
-
资助金额:$53.83万
-
财政年份:2018
-
负责人:Mario Stevenson
-
依托单位:
Revealing HIV-1 persistence in myeloid cell reservoirs
-
批准号:10319986
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2018
-
负责人:Mario Stevenson
-
依托单位:
Reservoir activity and recrudescent virus composition in HIV and SIV rebound
-
批准号:10205971
-
项目类别:
-
资助金额:$29.59万
-
财政年份:2017
-
负责人:Mario Stevenson
-
依托单位:
Reservoir activity and recrudescent virus composition in HIV and SIV rebound
-
批准号:9332149
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2017
-
负责人:Mario Stevenson
-
依托单位:
HIV-a Persistence in Myeloid Cell Reservoirs
-
批准号:9204094
-
项目类别:
-
资助金额:$19.19万
-
财政年份:2016
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists - Project 2
-
批准号:8723304
-
项目类别:
-
资助金额:$30.55万
-
财政年份:2014
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists - Core A
-
批准号:8723306
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2014
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists - Core A
-
批准号:8656186
-
项目类别:
-
资助金额:$4.9万
-
财政年份:2013
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists
-
批准号:8904721
-
项目类别:
-
资助金额:$119.44万
-
财政年份:2013
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists
-
批准号:9325570
-
项目类别:
-
资助金额:$116.85万
-
财政年份:2013
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists
-
批准号:8541369
-
项目类别:
-
资助金额:$126.23万
-
财政年份:2013
-
负责人:Mario Stevenson
-
依托单位:
Preclinical Development of HIV-1 Vif Antagonists
-
批准号:8723302
-
项目类别:
-
资助金额:$123.75万
-
财政年份:2013
-
负责人:Mario Stevenson
-
依托单位:
The role of myeloid cells in viral replication, persistence and neuroinvasion
-
批准号:8840999
-
项目类别:
-
资助金额:$35.82万
-
财政年份:2011
-
负责人:Mario Stevenson
-
依托单位:
The International Workshop on HIV Persistence During Therapy
-
批准号:8210430
-
项目类别:
-
资助金额:$2.0万
-
财政年份:2011
-
负责人:Mario Stevenson
-
依托单位:
ADM CORE
-
批准号:8271415
-
项目类别:
-
资助金额:$5.63万
-
财政年份:2011
-
负责人:Mario Stevenson
-
依托单位:
海外基金